Evidence map›Paper›PMID 28424581›Full record

ReviewFrontiers in neuroscience2017

Cerebral Pathology and Cognition in Diabetes: The Merits of Multiparametric Neuroimaging.

Frank C G van Bussel, Walter H Backes, Paul A M Hofman, Robert J van Oostenbrugge, Martin P J van Boxtel, Frans R J Verhey, Harry W M Steinbusch, Miranda T Schram, Coen D A Stehouwer, Joachim E Wildberger and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Soluble epoxide hydrolase-targeting PROTAC activates AMPK and inhibits endoplasmic reticulum stress.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. The diabetic brain and cognition.Journal of neural transmission (Vienna, Austria : 1996) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Frank C G van BusselDepartment of Radiology, Maastricht University Medical CenterMaastricht, Netherlands.
Walter H BackesDepartment of Radiology, Maastricht University Medical CenterMaastricht, Netherlands.
Paul A M HofmanDepartment of Radiology, Maastricht University Medical CenterMaastricht, Netherlands.
Robert J van OostenbruggeSchool for Mental Health and Neuroscience, Maastricht University Medical CenterMaastricht, Netherlands.
Martin P J van BoxtelSchool for Mental Health and Neuroscience, Maastricht University Medical CenterMaastricht, Netherlands.
Frans R J VerheySchool for Mental Health and Neuroscience, Maastricht University Medical CenterMaastricht, Netherlands.
Harry W M SteinbuschSchool for Mental Health and Neuroscience, Maastricht University Medical CenterMaastricht, Netherlands.
Miranda T SchramCardiovascular Research Institute Maastricht, Maastricht University Medical CenterMaastricht, Netherlands.
Coen D A StehouwerCardiovascular Research Institute Maastricht, Maastricht University Medical CenterMaastricht, Netherlands.
Joachim E WildbergerDepartment of Radiology, Maastricht University Medical CenterMaastricht, Netherlands.
Jacobus F A JansenDepartment of Radiology, Maastricht University Medical CenterMaastricht, Netherlands.
Maastricht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus is associated with accelerated cognitive decline and various cerebral abnormalities visible on MRI. The exact pathophysiological mechanisms underlying cognitive decline in diabetes still remain to be elucidated. In addition to conventional images, MRI offers a versatile set of novel contrasts, including blood perfusion, neuronal function, white matter microstructure, and metabolic function. These more-advanced multiparametric MRI contrasts and the pertaining parameters are able to reveal abnormalities in type 2 diabetes, which may be related to cognitive decline. To further elucidate the nature of the link between diabetes, cognitive decline, and brain abnormalities, and changes over time thereof, biomarkers are needed which can be provided by advanced MRI techniques. This review summarizes to what extent MRI, especially advanced multiparametric techniques, can elucidate the underlying neuronal substrate that reflects the cognitive decline in type 2 diabetes.

Indexed as

cognitionfunctional MRImagnetic resonance imagingmultiparametric MRItype 2 diabetes mellitus

Identifiers

PMID28424581
PMCPMC5380729
OpenAlexW2604700526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.